LRRK2 and Parkinson disease: In two subsequent efforts, midbrain-like organoids were produced from sporadic or familial PD patients carrying the LRRK2-G2019S mutation that, respectively, displayed αSyn accumulation and dopaminergic neuron degeneration [135,136].